Effects of induction with novel agents versus conventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myeloma

MM is the top indication for high-dose chemotherapy (HDC) with autologous stem cell transplantation (SCT), a strategy which improves progression-free survival and potentially overall survival. Novel induction regimens incorporating the immunomodulatory (IMID) agents thalidomide and lenalidomide, and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Benson, Don M, Panzner, Kathryn, Hamadani, Mehdi, Hofmeister, Craig C, Bakan, Courtney E, Smith, Megan K, Elder, Pat, Krugh, David, O’Donnell, Lynn, Devine, Steven M
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3557809/
https://ncbi.nlm.nih.gov/pubmed/20038230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428190903480728
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller